Blood test study for immune markers in miscarriage and IVF failure
Treatments studied
Part of Women’s health & pregnancy clinical trials.
This study looks at immune-related blood patterns and other measurements to better understand why some women have repeated pregnancy loss or repeated IVF implantation failure. If you qualify, your answers and test results may help researchers identify biomarkers that could guide future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 to 39
- You have a history of repeated implantation failure or unexplained recurrent spontaneous miscarriage
- Your prior work-up was negative, including ultrasound and hysteroscopy, parental chromosome tests, thyroid testing, and certain blood antibody tests
- Your hormone numbers fit the study: basic FSH is under 10 IU/L and AMH is above 1.5 ng/mL
- You have regular periods (about every 30 days, plus or minus 5 days) and you are starting a new IVF cycle (with or without ICSI)
- You can and will sign informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at immune cells inside the uterus to understand why some women have infertility or repeated miscarriages. You may join if you have had at least two miscarriages or certain benign gynecological conditions.
This study looks at whether a blood protein level called mannose binding lectin is linked to why some people have repeated pregnancy loss or unsuccessful embryo transfers. If you’ve had multiple losses or failed transfers, the study may help clarify biology behind reproduction and could guide future care.
This study looks at the lining of the uterus (womb) in women who have had repeated IVF failures or miscarriages, to see if differences in the lining's germs or immune system might play a role. The goal is to find ways to improve future fertility treatments.
This study tests embryos before pregnancy using genetic screening to look for extra or missing chromosomes, in people who have had repeated IVF embryo transfers without success. It may help reduce the chance of transferring embryos that are unlikely to result in a healthy pregnancy.
This Phase 3 study tests certolizumab to help people with repeated embryo transfer failures achieve a clinical pregnancy. It may be an option if your infertility has no known cause and you meet the other study checks.
This study tests whether a simple blood test taken before embryo transfer can help predict if the embryo will implant successfully. It is designed for women who have had unexplained repeated implantation failure and are planning another IVF cycle with frozen embryos.
Hear when a new Recurrent Miscarriage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.